Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9152196 | Respiratory Physiology & Neurobiology | 2005 | 10 Pages |
Abstract
This paper is devoted to the field of chemoreception and its role in the control of breathing in infants. We use “chemoreception” to refer to the capacity to sense and process changes in PO2 and PCO2, and also to react to these changes by adjusting ventilation in order to maintain homeostasis. Functional chemoreceptors are not essential to commence or even to sustain breathing efforts immediately at or after birth; the intense brain activation, which occurs at birth, is sufficient. Over subsequent days to weeks, however, this “neurogenic” drive weakens and drive from the chemoreceptors becomes critical for generating and maintaining a normal breathing rhythm. Failure of the chemoreceptors to develop normally, consequently, becomes an important underlying cause of breathing dysfunction, particularly during sleep. The paper deals with the methods available to study chemoreception in newborn infants and provide an overview of the early postnatal changes and interactions, which influence breathing at rest and under stress. The latter may be described in terms of the threshold and strength as well as the delay/speed with which ventilation changes in response to chemical stimulation. We conclude with a survey of disorders associated with chemoreceptor deficits in infancy.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Physiology
Authors
Gary Cohen, Miriam Katz-Salamon,